Judith Wiegant


Since 2010, Judith has been the director of Titus Health Care and is responsible for the overall management of THC and for managing the team members.

Team Titus Health Care - Judith

"I participate in Titus Health Care because our company is able to work in a different way. The added value we offer to women and our good relationships are key. We are responding to the current zeitgeist in which partnerships and alliances with companies are inextricably linked to our success. This has enabled us to bring gynaecological products to the Dutch market without doctor's visits. In the meantime, we have grown into an organisation that adds a lot of value to healthcare professionals through training and continuing education."

At Titus Health Care

After launching the T-Safe coil in 2010, Judith oversaw the market introduction of Esmya in 2012. In 2014, she was responsible for the addition of the Multi-Safe coil to THC's portfolio. In 2015, her responsibilities included the market introduction of Bemfola (Recombinant Follicle Stimulating Hormone) in the Netherlands. The introduction of Ballerine and the launch of the Electronic Prescription System AnticonceptiePortaal followed in 2019.

Finally, Judith is in charge of all GDP (Good Distribution Practices) related matters, such as maintenance of the pharmaceutical wholesale licence that was granted in 2014.

Previous experience

Before Judith was asked to participate in Titus Health Care in 2010, she worked as a project and key account manager at MerckSerono and AstraZeneca. There Judith was responsible for the Opinion Leader Management and implementation of the marketing strategy. Furthermore, she supervised strategic projects, such as ISO certification and implementation of fertility EPDs. She also participated in the Fertimagazine Board, a website for women with fertility problems.

In addition to her work, Judith is closely involved with the El Fuego Foundation.